BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 885 filers reported holding BAXTER INTL INC in Q3 2023. The put-call ratio across all filers is 0.40 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $222,968 | -19.9% | 5,908 | -3.3% | 0.02% | -16.0% |
| Q2 2023 | $278,235 | +10.5% | 6,107 | -1.6% | 0.02% | +8.7% |
| Q1 2023 | $251,756 | -20.4% | 6,207 | 0.0% | 0.02% | -20.7% |
| Q4 2022 | $316,371 | -6.9% | 6,207 | -1.6% | 0.03% | -14.7% |
| Q3 2022 | $340,000 | -39.5% | 6,307 | -28.0% | 0.03% | -35.8% |
| Q2 2022 | $562,000 | -17.6% | 8,757 | -0.4% | 0.05% | -1.9% |
| Q1 2022 | $682,000 | -4.3% | 8,790 | +5.8% | 0.05% | -3.6% |
| Q4 2021 | $713,000 | +6.6% | 8,307 | 0.0% | 0.06% | 0.0% |
| Q3 2021 | $669,000 | 0.0% | 8,307 | 0.0% | 0.06% | -3.4% |
| Q2 2021 | $669,000 | -4.8% | 8,307 | -0.4% | 0.06% | -12.1% |
| Q1 2021 | $703,000 | +0.1% | 8,342 | -4.7% | 0.07% | -4.3% |
| Q4 2020 | $702,000 | -3.3% | 8,756 | -2.9% | 0.07% | -9.2% |
| Q3 2020 | $726,000 | +7.9% | 9,020 | +15.3% | 0.08% | -7.3% |
| Q2 2020 | $673,000 | +7.5% | 7,820 | +1.4% | 0.08% | -11.8% |
| Q1 2020 | $626,000 | -5.4% | 7,715 | -2.5% | 0.09% | +22.4% |
| Q4 2019 | $662,000 | -4.3% | 7,915 | 0.0% | 0.08% | -12.6% |
| Q3 2019 | $692,000 | +6.8% | 7,915 | 0.0% | 0.09% | +16.0% |
| Q2 2019 | $648,000 | -25.0% | 7,915 | -25.4% | 0.08% | -15.7% |
| Q1 2019 | $864,000 | +21.3% | 10,615 | -1.8% | 0.09% | +8.5% |
| Q4 2018 | $712,000 | -13.3% | 10,815 | +1.5% | 0.08% | -2.4% |
| Q3 2018 | $821,000 | +1.0% | 10,651 | -3.1% | 0.08% | -7.7% |
| Q2 2018 | $813,000 | +12.6% | 10,995 | -0.9% | 0.09% | +9.6% |
| Q1 2018 | $722,000 | +0.6% | 11,095 | 0.0% | 0.08% | +6.4% |
| Q4 2017 | $718,000 | +10.5% | 11,095 | +7.2% | 0.08% | +6.8% |
| Q3 2017 | $650,000 | +3.7% | 10,345 | 0.0% | 0.07% | -9.9% |
| Q2 2017 | $627,000 | +28.7% | 10,345 | +10.1% | 0.08% | +26.6% |
| Q1 2017 | $487,000 | +18.8% | 9,395 | +1.8% | 0.06% | +8.5% |
| Q4 2016 | $410,000 | +57.1% | 9,230 | +147.3% | 0.06% | +63.9% |
| Q2 2015 | $261,000 | +10.6% | 3,732 | +8.3% | 0.04% | +5.9% |
| Q1 2015 | $236,000 | -10.3% | 3,445 | -4.2% | 0.03% | -17.1% |
| Q4 2014 | $263,000 | -12.9% | 3,595 | -14.5% | 0.04% | -10.9% |
| Q3 2014 | $302,000 | -0.7% | 4,205 | 0.0% | 0.05% | -8.0% |
| Q2 2014 | $304,000 | -55.3% | 4,205 | -54.5% | 0.05% | -54.5% |
| Q1 2014 | $680,000 | +12.6% | 9,243 | +6.5% | 0.11% | +10.0% |
| Q4 2013 | $604,000 | +6.0% | 8,680 | +0.0% | 0.10% | -5.7% |
| Q3 2013 | $570,000 | -1.7% | 8,679 | +3.6% | 0.11% | -13.8% |
| Q2 2013 | $580,000 | – | 8,381 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 200,000 | $7,548,000 | 6.60% |
| BOONE CAPITAL MANAGEMENT LLC | 469,405 | $17,715,345 | 5.59% |
| Soditic Asset Management LLP | 186,920 | $7,054,361 | 5.43% |
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 131,000 | $4,943,940 | 4.32% |
| Camber Capital Management LP | 3,000,000 | $113,220 | 3.73% |
| Carmignac Gestion | 4,848,773 | $182,991,718 | 3.36% |
| SHAPIRO CAPITAL MANAGEMENT LLC | 3,028,799 | $114,306,874 | 3.33% |
| Hillman Capital Management, Inc. | 219,248 | $8,274,420 | 3.19% |
| Cincinnati Specialty Underwriters Insurance CO | 201,500 | $7,604,610 | 2.90% |
| Callodine Capital Management, LP | 265,000 | $10,001,100 | 2.79% |